Literature DB >> 15668653

Limb salvage management of pathologic fractures of primary malignant bone tumors.

Walid Ebeid1, Sherif Amin, Amr Abdelmegid.   

Abstract

BACKGROUND: Little is known about oncologic outcomes of patients with primary bone tumors complicated by a pathologic fracture and treated by limb salvage.
METHODS: Our study included 17 men and 14 women aged 6 to 61 years (average age 17 years). All 31 patients had primary bone tumors complicated by a pathologic fracture. Diagnoses included osteosarcoma (17 patients), Ewing's sarcoma (10), malignant fibrous histiocytoma (3), and lymphoma (1). All received preoperative chemotherapy. The distal femur was affected in 13 patients, the proximal femur in 6, mid shaft femur in 4, the proximal humerus in 4, the proximal tibia in 3, and the fibula in 1. All patients underwent limb salvage and achieved a wide resection margin.
RESULTS: The average follow-up period was 18 months (range 8 to 51 months). Two patients required amputation due to local recurrence. Six patients developed pulmonary metastases and eventually died.
CONCLUSIONS: A pathologic fracture of primary bone tumor is not always a contraindication for limb salvage since the oncologic outcome appears acceptable.

Entities:  

Mesh:

Year:  2005        PMID: 15668653     DOI: 10.1177/107327480501200107

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  10 in total

1.  Two case-reports of the limb salvage treatment of osteosarcoma consolidated with obvious pathological fractures.

Authors:  Q Cui; D F Li; C Liu; J Guo; S B Liu; Y S Liu; J M Zhai; Yanjun Zeng
Journal:  Pathol Oncol Res       Date:  2011-01-09       Impact factor: 3.201

2.  Meta-analysis of the prognosis after surgical treatment of osteosarcoma complicated by pathologic fracture.

Authors:  Wei Zhong; Ziyi Wu; Yuhao Yuan; Wei Luo
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

3.  The impact of pathological fractures on therapy outcome in patients with primary malignant bone tumours.

Authors:  Babak Moradi; Anita Zahlten-Hinguranage; Burkhard Lehner; Felix Zeifang
Journal:  Int Orthop       Date:  2009-12-13       Impact factor: 3.075

4.  Limb salvage surgery in bone tumors: a retrospective study of 50 cases in a single center.

Authors:  Ashutosh Chauhan; G R Joshi; B K Chopra; Manomoy Ganguly; G R Reddy
Journal:  Indian J Surg Oncol       Date:  2013-03-20

5.  Pathological fracture of the proximal femur in osteosarcoma: need for early radical surgery?

Authors:  C R Chandrasekar; R J Grimer; S R Carter; R M Tillman; A Abudu; L M Jeys; W G H Cheung; R Sharma
Journal:  ISRN Oncol       Date:  2012-03-18

6.  Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case-control study.

Authors:  Dongqing Zuo; Longpo Zheng; Wei Sun; Yingqi Hua; Zhengdong Cai
Journal:  World J Surg Oncol       Date:  2013-06-24       Impact factor: 2.754

7.  Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.

Authors:  Lien-Hsiang Chung; Po-Kuei Wu; Cheng-Fong Chen; Hung-Kai Weng; Tain-Hsiung Chen; Wei-Ming Chen
Journal:  BMC Musculoskelet Disord       Date:  2016-12-28       Impact factor: 2.362

8.  A Retrospective Cohort Analysis of Limb Salvage Surgery Using Mega Prosthesis in Bone Tumours at a Tertiary Care Centre in Eastern India.

Authors:  Nishant Kashyap; Ritesh Runu; Wasim Ahmed; Indrajeet Kumar; Abhijeet Subash
Journal:  Cureus       Date:  2022-09-08

9.  Meta-analysis of limb salvage versus amputation for treating high-grade and localized osteosarcoma in patients with pathological fracture.

Authors:  Ke Yin; Qiande Liao; DA Zhong; Jie Ding; Bing Niu; Qiupping Long; Dengfeng Ding
Journal:  Exp Ther Med       Date:  2012-08-28       Impact factor: 2.447

Review 10.  A comparative study between limb-salvage and amputation for treating osteosarcoma.

Authors:  Xiaojuan Li; Ya Zhang; Shanshan Wan; Huiling Li; Dongqi Li; Junfeng Xia; Zhongqin Yuan; Mingyan Ren; Shunling Yu; Su Li; Yihao Yang; Lei Han; Zuozhang Yang
Journal:  J Bone Oncol       Date:  2016-01-23       Impact factor: 4.072

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.